Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Main features of the Dutch DRG package of specialist medical care in 2019

13 Dec 2017

The Dutch Health Care Authority (NZa) has published the main features of the DBC package for specialist medical care in 2019 (RZ19a) with an explanation of the most important proposed changes in regulations, DBC structure, and tariffs.

The following types of care will be implemented in 2019:

  • Pediatric oncology: in 2019, NZa make will make it possible to record recurrence treatment for pediatric oncology.
  • Proton therapy: since January 1, 2019, proton therapy will be included in the product structure of the DBC system for hospital care.
  • Telemedicine: E-health can make health care better, more comfortable and probably cheaper. That is why the NZa wants to stimulate the use of e-health applications, and innovation/e-health development is part of its strategy. In the 2018 DBC package, NZa made it possible for remote consultations to be reimbursed. Reimbursement for telemedicine is proposed for 2019. Until 2019, telemedicine was a part of the outpatient clinic visit. However, telemedicine for monitoring patient is always accompanied by (tele) guidance in the form of repeated outpatient visits (physical visit, call and/or written form).  Since 2019, the outpatient clinic visit has been removed from the telemonitoring care activity, and telemedicine, thus, becomes a billable health product.

See full details in the Dutch here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.